Episode
Episode 59. Management of Systemic Mastocytosis with Dr. Daniel DeAngelo
- Podcast
- Blood Cancer Talks
- Published
- May 8, 2025
- Duration seconds
- 3798
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/589af0c1
Actions
POST https://stenobird.com/v1/public/podcasts/blood-cancer-talks-5570002/episodes/episode-59-management-of-systemic-mastocytosis-with-dr-daniel-deangelo/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/blood-cancer-talks-5570002/episode-59-management-of-systemic-mastocytosis-with-dr-daniel-deangelo.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, we discussed the management of systemic mastocytosis with Dr. Daniel DeAngelo from the Dana Farber Cancer Institute. Here are the key studies we discussed: Midostaurin https://www.nejm.org/doi/10.1056/NEJMoa1513098?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov Avapritinib EXLPORER study: https://www.nature.com/articles/s41591-021-01538-9 PATHFINDER study: https://www.nature.com/articles/s41591-021-01539-8 Bezuclastinib: APEX trial: https://ashpublications.org/blood/article/144/Supplement%201/659/530240/Apex-Part-1-Updated-Assessment-of-Bezuclastinib HSCT for Advanced SM: https://ascopubs.org/doi/10.1200/JCO.2014.55.2018